GLOBAL APHERESIS MARKET FORECAST 2021-2028

The global apheresis market is anticipated to register a CAGR of 8.31% between 2021 and 2028, and is projected to generate revenue of $4366.2 million by 2028.  

Apheresis is a medical technique that includes eliminating whole blood from a patient or donor and separating the plasma into distinct mechanisms to remove one specific component. 

global-apheresis-market

Key factors propelling the global apheresis market growth are:

  • Prevailing incidence of hematologic diseases
    • Blood diseases affect one or more parts of the body as well as total health. There are various blood diseases caused by certain genes. The growing incidence of anemia, hemophilia, and von Willebrand disease (VWD), demands the need for a blood transfusion, which is expected to increase the requirement of apheresis equipment
  • Advancement in technologies of apheresis technique
  • Favorable reimbursement policies and funding for apheresis procedures
  • Growing geriatric population

Major growth restraining factors:

  • Risk of blood contamination while conducting transfusions
  • High cost of investment associated with apheresis procedures
  • Lack of skilled professionals in developing and underdeveloped countries
    • The shortage of skilled professionals is one of the critical challenges faced by the apheresis market, which hampers the market growth in most developing and underdeveloped countries.

The report scope of the global apheresis market includes the segmentation analysis of procedure, technology, product, application, and end-user.

Market by Application:

  • Hematological Disorders
    • Hematological disorders are the major revenue-generating application.
    • The increasing hematological incidences globally, and the growing apheresis applications for treating them, aid the overall market growth.
  • Neurological Disorders
    • Neurological disorders are the fastest-growing application.
    • Plasma exchange therapy and immunoadsorption therapy were found to be effective for treating immune-mediated neurological disorders. Apheresis therapy is highly being explored for the treatment of Alzheimer’s disease.
  • Autoimmune Disorders
  • Renal Disorders
  • Other Applications

Geographically, the global apheresis market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America is evaluated to harbor the largest revenue share by 2028.
    • The increasing demand for blood components and growing concerns regarding blood safety, the rising prevalence of various blood disorders, a growing number of surgical procedures, and emergency care cases in hospitals in the region contribute to the market growth.
  • Europe: Germany, the United Kingdom, Russia, France, Italy, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific
  • Rest of World: Latin America, the Middle East & Africa

The major players in the global apheresis market are:

    • Asahi Kasei Corporation
    • Baxter International Inc
    • B Braun Melsungen AG
    • Kaneka Corporation
    • Terumo Corporation (Terumo BCT)
    • Others

Key strategies adopted by some of the apheresis companies:

In March 2021, CytoSorbents Corporation and B. Braun Avitum AG announced a Co-Marketing contract to promote the OMNI Continuous Blood Purification Platform with CytoSorb.

Key findings of the global apheresis market:

  • There have been developments in therapeutic apheresis.
  • The number of patients suffering from kidney, blood, neurological, and metabolic disorders is rising.
  • There is a growing demand for hematology disease services.

 

Frequently Asked Questions (FAQs):

Currently, several developments are being done to leverage the potential that this market has to offer to increase the applicability of these apheresis procedures. For instance, in January 2020, Fresenius Kabi inaugurated a EUR 30 million transfusion expansion and apheresis disposables plant in the Dominican Republic, which is expected to impact the market growth.
In people aged 75 and above, high blood pressure is the common risk factor for hematological diseases, including blood-associated cancer. Hence, an apheresis procedure is needed to transfuse blood among the geriatric populations, which drives the market growth.
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVAILING INCIDENCE OF HEMATOLOGIC DISEASES
      2. ADVANCEMENT IN TECHNOLOGIES OF APHERESIS TECHNIQUE
      3. FAVORABLE REIMBURSEMENT POLICIES AND FUNDING FOR APHERESIS PROCEDURES
      4. GROWING GERIATRIC POPULATION
    2. KEY RESTRAINTS
      1. RISK OF BLOOD CONTAMINATION WHILE CONDUCTING TRANSFUSIONS
      2. HIGH COST OF INVESTMENT ASSOCIATED WITH APHERESIS PROCEDURES
      3. LACK OF SKILLED PROFESSIONALS IN DEVELOPING AND UNDERDEVELOPED COUNTRIES
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON APHERESIS MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRY
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY PROCEDURE
    1. PLASMAPHERESIS
    2. PLATELETPHERESIS
    3. LEUKAPHERESIS
    4. ERYTHROCYTAPHERESIS
    5. OTHER APHERESIS PROCEDURES
  6. MARKET BY TECHNOLOGY
    1. CENTRIFUGATION
    2. MEMBRANE SEPARATION
  7. MARKET BY PRODUCT
    1. DISPOSABLE APHERESIS KITS
    2. APHERESIS MACHINE
  8. MARKET BY APPLICATION
    1. HEMATOLOGICAL DISORDERS
    2. NEUROLOGICAL DISORDERS
    3. AUTOIMMUNE DISORDERS
    4. RENAL DISORDERS
    5. OTHER APPLICATIONS
  9. MARKET BY END-USER
    1. BLOOD BANKS/ BLOOD DONATION CENTERS
    2. HOSPITALS & CLINICS
    3. AMBULATORY SURGICAL CENTERS
  10. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. UNITED STATES
        2. CANADA
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. GERMANY
        2. FRANCE
        3. UNITED KINGDOM
        4. ITALY
        5. RUSSIA
        6. BELGIUM
        7. POLAND
        8. REST OF EUROPE
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. INDIA
        4. AUSTRALIA & NEW ZEALAND
        5. SOUTH KOREA
        6. INDONESIA
        7. THAILAND
        8. VIETNAM
        9. REST OF ASIA-PACIFIC
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGE
      4. KEY PLAYERS
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
        2. MIDDLE EAST & AFRICA
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    2. COMPANY PROFILES
      1. ASAHI KASEI CORPORATION
      2. BAXTER INTERNATIONAL INC
      3. B BRAUN MELSUNGEN AG
      4. CERUS CORPORATION
      5. CYTOSORBENTS CORPORATION
      6. FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
      7. HAEMONETICS CORPORATION
      8. HEMACARE CORPORATION
      9. INFOMED
      10. KANEKA CORPORATION
      11. KAWASUMI LABORATORIES INC
      12. MEDICAP CLINIC GMBH
      13. MEDICA SPA
      14. MILTENYI BIOTEC
      15. TERUMO CORPORATION (TERUMO BCT)
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - APHERESIS

TABLE 2: GLOBAL APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL PLASMAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL PLASMAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL PLATELETPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL PLATELETPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL LEUKAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL LEUKAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL ERYTHROCYTAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL ERYTHROCYTAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL OTHER APHERESIS PROCEDURES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL OTHER APHERESIS PROCEDURES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL CENTRIFUGATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL CENTRIFUGATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL MEMBRANE SEPARATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL MEMBRANE SEPARATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL DISPOSABLE APHERESIS KITS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL DISPOSABLE APHERESIS KITS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL APHERESIS MACHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL APHERESIS MACHINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL HEMATOLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL HEMATOLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL RENAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL RENAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: GLOBAL BLOOD BANKS/ BLOOD DONATION CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: GLOBAL BLOOD BANKS/ BLOOD DONATION CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 43: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 44: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: GLOBAL APHERESIS MARKET, BY REGION, HISTORIC YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: GLOBAL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 49: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 50: LEADING PLAYERS OPERATING IN NORTH AMERICA APHERESIS MARKET

TABLE 51: EUROPE APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 52: EUROPE APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 53: LEADING PLAYERS OPERATING IN EUROPE APHERESIS MARKET

TABLE 54: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, HISTORIC YEARS, 2016-2020 (IN $ MILLION)

TABLE 55: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 56: LEADING PLAYERS OPERATING IN ASIA-PACIFIC APHERESIS MARKET

TABLE 57: REST OF WORLD APHERESIS MARKET, BY REGION, HISTORIC YEARS, 2016-2020 (IN $ MILLION)

TABLE 58: REST OF WORLD APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 59: LEADING PLAYERS OPERATING IN REST OF WORLD APHERESIS MARKET

TABLE 60: LIST OF MERGERS & ACQUISITIONS

TABLE 61: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 62: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 63: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL APHERESIS MARKET, BY PROCEDURE, IN 2020

FIGURE 6: GLOBAL APHERESIS MARKET, BY PLASMAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL APHERESIS MARKET, BY PLATELETPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL APHERESIS MARKET, BY LEUKAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL APHERESIS MARKET, BY ERYTHROCYTAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL APHERESIS MARKET, BY OTHER APHERESIS PROCEDURES, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, IN 2020

FIGURE 12: GLOBAL APHERESIS MARKET, BY CENTRIFUGATION, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL APHERESIS MARKET, BY MEMBRANE SEPARATION, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL APHERESIS MARKET, BY PRODUCT, IN 2020

FIGURE 15: GLOBAL APHERESIS MARKET, BY DISPOSABLE APHERESIS KITS, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL APHERESIS MARKET, BY APHERESIS MACHINE, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL APHERESIS MARKET, BY APPLICATION, IN 2020

FIGURE 18: GLOBAL APHERESIS MARKET, BY HEMATOLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: PREVALENCE OF BLEEDING DISORDER GLOBALLY, IN 2019

FIGURE 20: GLOBAL APHERESIS MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL APHERESIS MARKET, BY AUTOIMMUNE DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL APHERESIS MARKET, BY RENAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL APHERESIS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL APHERESIS MARKET, BY END-USER, IN 2020

FIGURE 25: GLOBAL APHERESIS MARKET, BY BLOOD BANKS/ BLOOD DONATION CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL APHERESIS MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL APHERESIS MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 29: UNITED STATES APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: CANADA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: EUROPE APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 32: GERMANY APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: FRANCE APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: UNITED KINGDOM APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: ITALY APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: RUSSIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: BELGIUM APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: POLAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: REST OF EUROPE APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: ASIA-PACIFIC APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 41: CHINA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: JAPAN APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: INDIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: AUSTRALIA & NEW ZEALAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: SOUTH KOREA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: INDONESIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: THAILAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: VIETNAM APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: REST OF ASIA-PACIFIC APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: REST OF WORLD APHERESIS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 51: LATIN AMERICA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: MIDDLE EAST & AFRICA APHERESIS MARKET, 2021-2028 (IN $ MILLION) 

Request For A Free Sample